Payment overview · 2025
General Payments
$308.56
16 reported records · 11 companies
Healthcare provider profile · identity verified
John W Richardson, MD
Allopathic & Osteopathic Physicians|Family Medicine · DECATUR, TX · NPI 1659311850
Verified facts
What the public records show
CMS Open Payments records show John W Richardson, MD received $308.56 in general payments during 2025 across 16 reported records.
Abbott Laboratories accounted for 23.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 19 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Mounjaro, Ozempic, Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 84 claims for Trelegy Ellipta by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 181 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 104 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 235 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Tresiba as an associated drug or biological on 415 records involving 264 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Tresiba by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 862 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $71.47 | 23.2% | 2 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $40.75 | 13.2% | 2 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $25.93 | 8.4% | 4 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $25.02 | 8.1% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $24.68 | 8.0% | 1 | 2025 |
| IBSA Pharma Inc. | Unresolved — no canonical attribution shown | $24.55 | 8.0% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $21.75 | 7.0% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $20.61 | 6.7% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $20.12 | 6.5% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $18.88 | 6.1% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $14.80 | 4.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $308.56 | 16 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $40.75 | 2 | 2025 |
Source payment records
|
|||||
| ASSURITY Normalized: assurity |
Device | Abbott Laboratories | $38.16 | 1 | 2025 |
Source payment records
|
|||||
| AVEIR Normalized: aveir |
Device | Abbott Laboratories | $33.31 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $25.93 | 4 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $25.02 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $25.02 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $24.68 | 1 | 2025 |
Source payment records
|
|||||
| Flector Normalized: flector |
Drug | IBSA Pharma Inc. | $24.55 | 1 | 2025 |
Source payment records
|
|||||
| Licart Normalized: licart |
Drug | IBSA Pharma Inc. | $24.55 | 1 | 2025 |
Source payment records
|
|||||
| Tirosint Normalized: tirosint |
Drug | IBSA Pharma Inc. | $24.55 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $24.01 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $21.75 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $21.75 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $20.61 | 1 | 2025 |
Source payment records
|
|||||
| Repatha Normalized: repatha |
Biological | Amgen Inc. | $20.12 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $18.88 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $16.74 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $14.80 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $14.80 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 862 | exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 34 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 235 | exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 84 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
84 | 18 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
181 | 32 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
34 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
104 | 19 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
235 | 55 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Tresiba open payments reported associated product |
CMS Open Payments — General Payments 415 supporting records · 264 recipient NPIs · example record 1188130328 |
Tresiba · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
862 | 126 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
24 | 24 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 2121 | 412 |
| Furosemide | Furosemide | 1694 | 320 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1525 | 360 |
| Amlodipine Besylate | Amlodipine Besylate | 1453 | 334 |
| Gabapentin | Gabapentin | 1238 | 269 |
| Potassium Chloride | Potassium Chloride | 1237 | 252 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1203 | 272 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1032 | 273 |
| Lisinopril | Lisinopril | 998 | 243 |
| Losartan Potassium | Losartan Potassium | 918 | 223 |
| Eliquis | Apixaban | 862 | 126 |
| Sertraline Hcl | Sertraline Hcl | 857 | 167 |
| Trazodone Hcl | Trazodone Hcl | 851 | 181 |
| Tamsulosin Hcl | Tamsulosin Hcl | 788 | 179 |
| Metoprolol Succinate | Metoprolol Succinate | 727 | 179 |
| Carvedilol | Carvedilol | 653 | 140 |
| Metformin Hcl | Metformin Hcl | 645 | 162 |
| Mirtazapine | Mirtazapine | 614 | 124 |
| Montelukast Sodium | Montelukast Sodium | 601 | 146 |
| Donepezil Hcl | Donepezil Hcl | 588 | 106 |
| Omeprazole | Omeprazole | 539 | 140 |
| Escitalopram Oxalate | Escitalopram Oxalate | 533 | 107 |
| Duloxetine Hcl | Duloxetine Hcl | 503 | 96 |
| Meloxicam | Meloxicam | 498 | 113 |
| Pravastatin Sodium | Pravastatin Sodium | 483 | 121 |
| Memantine Hcl | Memantine Hcl | 481 | 74 |
| Clopidogrel | Clopidogrel Bisulfate | 472 | 108 |
| Tramadol Hcl | Tramadol Hcl | 460 | 147 |
| Allopurinol | Allopurinol | 454 | 84 |
| Metoprolol Tartrate | Metoprolol Tartrate | 450 | 107 |
| Fluticasone Propionate | Fluticasone Propionate | 412 | 149 |
| Hydrochlorothiazide | Hydrochlorothiazide | 392 | 108 |
| Famotidine | Famotidine | 384 | 94 |
| Bupropion Xl | Bupropion Hcl | 351 | 68 |
| Simvastatin | Simvastatin | 349 | 75 |
| Alprazolam | Alprazolam | 347 | 70 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 344 | 85 |
| Finasteride | Finasteride | 343 | 82 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 330 | 70 |
| Diclofenac Sodium | Diclofenac Sodium | 327 | 121 |
| Alendronate Sodium | Alendronate Sodium | 314 | 65 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 294 | 56 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 283 | 41 |
| Citalopram Hbr | Citalopram Hydrobromide | 272 | 64 |
| Tizanidine Hcl | Tizanidine Hcl | 269 | 93 |
| Prednisone | Prednisone | 257 | 153 |
| Ezetimibe | Ezetimibe | 235 | 62 |
| Ozempic | Semaglutide | 235 | 55 |
| Glimepiride | Glimepiride | 224 | 59 |
| Zolpidem Tartrate | Zolpidem Tartrate | 224 | 49 |
| Warfarin Sodium | Warfarin Sodium | 223 | 35 |
| Pregabalin | Pregabalin | 218 | 39 |
| Ondansetron Hcl | Ondansetron Hcl | 216 | 107 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 204 | 87 |
| Oxybutynin Chloride | Oxybutynin Chloride | 200 | 60 |
| Myrbetriq | Mirabegron | 199 | 31 |
| Levetiracetam | Levetiracetam | 192 | 28 |
| Ropinirole Hcl | Ropinirole Hcl | 192 | 37 |
| Hydralazine Hcl | Hydralazine Hcl | 187 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 183 | 48 |
| Jardiance | Empagliflozin | 181 | 32 |
| Xarelto | Rivaroxaban | 174 | 30 |
| Buspirone Hcl | Buspirone Hcl | 173 | 41 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 169 | 39 |
| Spironolactone | Spironolactone | 163 | 34 |
| Doxycycline Hyclate | Doxycycline Hyclate | 155 | 114 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 152 | 45 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 147 | 117 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 137 | 89 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 134 | 36 |
| Amoxicillin | Amoxicillin | 132 | 115 |
| Divalproex Sodium | Divalproex Sodium | 132 | 28 |
| Calcitriol | Calcitriol | 131 | 28 |
| Celecoxib | Celecoxib | 125 | 36 |
| Cephalexin | Cephalexin | 125 | 108 |
| Metformin Hcl Er | Metformin Hcl | 125 | 29 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 125 | 85 |
| Cefdinir | Cefdinir | 122 | 96 |
| Methylprednisolone | Methylprednisolone | 122 | 112 |
| Albuterol Sulfate | Albuterol Sulfate | 121 | 57 |
| Primidone | Primidone | 119 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 116 | 31 |
| Estradiol | Estradiol | 114 | 28 |
| Aripiprazole | Aripiprazole | 111 | 25 |
| Azithromycin | Azithromycin | 111 | 102 |
| Nystatin | Nystatin | 110 | 76 |
| Digoxin | Digoxin | 109 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 106 | 23 |
| Trulicity | Dulaglutide | 104 | 19 |
| Lorazepam | Lorazepam | 102 | 42 |
| Topiramate | Topiramate | 100 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 99 | 25 |
| Azelastine Hcl | Azelastine Hcl | 96 | 39 |
| Meclizine Hcl | Meclizine Hcl | 94 | 45 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 93 | 19 |
| Tresiba Flextouch U-100 | Insulin Degludec | 92 | 15 |
| Colestipol Hcl | Colestipol Hcl | 91 | 17 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 90 | 16 |
| Synthroid | Levothyroxine Sodium | 89 | 29 |
| Farxiga | Dapagliflozin Propanediol | 88 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 87 | 23 |
| Fenofibrate | Fenofibrate | 87 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 86 | 20 |
| Lamotrigine | Lamotrigine | 85 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 84 | 22 |
| Methocarbamol | Methocarbamol | 84 | 33 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 84 | 26 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 84 | 18 |
| Baclofen | Baclofen | 82 | 16 |
| Ramipril | Ramipril | 81 | 21 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 80 | 16 |
| Clonazepam | Clonazepam | 79 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 78 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 77 | 21 |
| Glipizide | Glipizide | 77 | 18 |
| Lovastatin | Lovastatin | 77 | 16 |
| Bumetanide | Bumetanide | 76 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | 24 |
| Sucralfate | Sucralfate | 74 | 13 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 73 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 73 | 17 |
| Atenolol | Atenolol | 71 | 22 |
| Fluconazole | Fluconazole | 69 | 53 |
| Insulin Aspart Flexpen | Insulin Aspart | 69 | 14 |
| Clonidine Hcl | Clonidine Hcl | 67 | 19 |
| Nifedipine Er | Nifedipine | 67 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 64 | 15 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 64 | 25 |
| Ipratropium Bromide | Ipratropium Bromide | 61 | 22 |
| Valacyclovir | Valacyclovir Hcl | 61 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 60 | 20 |
| Levofloxacin | Levofloxacin | 60 | 49 |
| Minoxidil | Minoxidil | 60 | 11 |
| Eszopiclone | Eszopiclone | 57 | suppressed |
| Januvia | Sitagliptin Phosphate | 56 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 54 | 50 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 49 | 44 |
| Benazepril Hcl | Benazepril Hcl | 48 | 14 |
| Felodipine Er | Felodipine | 48 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 48 | 27 |
| Temazepam | Temazepam | 48 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 47 | 12 |
| Entresto | Sacubitril/Valsartan | 45 | suppressed |
| Risperidone | Risperidone | 45 | 17 |
| Irbesartan | Irbesartan | 44 | 11 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 44 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 43 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 43 | suppressed |
| Olanzapine | Olanzapine | 43 | 11 |
| Sumatriptan Succinate | Sumatriptan Succinate | 43 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 43 | 13 |
| Telmisartan | Telmisartan | 43 | 11 |
| Latanoprost | Latanoprost | 42 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 41 | 14 |
| Propranolol Hcl | Propranolol Hcl | 41 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 41 | suppressed |
| Budesonide | Budesonide | 40 | 12 |
| Bupropion Hcl Sr | Bupropion Hcl | 40 | suppressed |
| Ondansetron Odt | Ondansetron | 40 | 19 |
| Oxcarbazepine | Oxcarbazepine | 40 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 39 | 12 |
| Midodrine Hcl | Midodrine Hcl | 39 | 13 |
| Novolog Flexpen | Insulin Aspart | 39 | 16 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 38 | 37 |
| Torsemide | Torsemide | 38 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 37 | 19 |
| Methimazole | Methimazole | 37 | suppressed |
| Colchicine | Colchicine | 35 | 12 |
| Glipizide Er | Glipizide | 35 | suppressed |
| Mounjaro | Tirzepatide | 34 | suppressed |
| Mupirocin | Mupirocin | 34 | 28 |
| Propranolol Hcl Er | Propranolol Hcl | 34 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 33 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 33 | suppressed |
| Anastrozole | Anastrozole | 32 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 31 | 18 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 31 | 15 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 31 | 13 |
| Klor-Con 10 | Potassium Chloride | 31 | 13 |
| Metronidazole | Metronidazole | 31 | 25 |
| Sodium Chloride | 0.9 % Sodium Chloride | 31 | 23 |
| Verapamil Er | Verapamil Hcl | 31 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 30 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 30 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 29 | 14 |
| Mirabegron Er | Mirabegron | 29 | 13 |
| Phenobarbital | Phenobarbital | 29 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 28 | suppressed |
| Naproxen | Naproxen | 28 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 27 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Folic Acid | Folic Acid | 27 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 27 | suppressed |
| Acyclovir | Acyclovir | 26 | 11 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 26 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 25 | suppressed |
| Gemtesa | Vibegron | 25 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Tradjenta | Linagliptin | 25 | suppressed |
| Vraylar | Cariprazine Hcl | 25 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Lidocaine | Lidocaine | 24 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 24 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 24 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 24 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 24 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 23 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 23 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 23 | suppressed |
| Metolazone | Metolazone | 23 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 22 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 22 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 22 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 21 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 21 | 11 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 21 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 21 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 20 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Nystop | Nystatin | 20 | 14 |
| Prednisolone Acetate | Prednisolone Acetate | 20 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 20 | 12 |
| Candesartan Cilexetil | Candesartan Cilexetil | 19 | suppressed |
| Creon | Lipase/Protease/Amylase | 19 | suppressed |
| Levemir Flexpen | Insulin Detemir | 19 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 19 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 18 | suppressed |
| Fluorouracil | Fluorouracil | 18 | 18 |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 17 | suppressed |
| Corlanor | Ivabradine Hcl | 17 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Ibuprofen | Ibuprofen | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Lacosamide | Lacosamide | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Armour Thyroid | Thyroid,pork | 16 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Rivastigmine | Rivastigmine | 16 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 16 | 13 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 16 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Insulin Lispro | Insulin Lispro | 15 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 15 | 11 |
| Premarin | Estrogens, Conjugated | 15 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Fluorometholone | Fluorometholone | 14 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 14 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 14 | suppressed |
| Tresiba | Insulin Degludec | 14 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Neupro | Rotigotine | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Ubrelvy | Ubrogepant | 13 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 12 | suppressed |
| Insulin Aspart | Insulin Aspart | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Perphenazine | Perphenazine | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $308.56 · 16 records | Abbott Laboratories | AREXVY, ASSURITY, AVEIR, Dexcom G6 Transmitter, ELIQUIS, Flector, INGREZZA, Licart, MOUNJARO, NURTEC ODT, Ozempic, Repatha, Rybelsus, SHINGRIX, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Tirosint, VOQUEZNA, ZEPBOUND | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error